| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cullinan Oncology, Inc. | Chief Scientific Officer | Common Stock | 341,434 | $4,254,268 | $12.46 | 17 Feb 2023 | Indirect |
| Cullinan Oncology, Inc. | Chief Scientific Officer | Common Stock | 76,000 | $946,960 | $12.46 | 17 Feb 2023 | Direct |
| Cullinan Oncology, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 77,000 | 17 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Oncology, Inc. | 17 Feb 2023 | 2 | $0 | 4 | Chief Scientific Officer | 21 Feb 2023, 17:53 |
| CGEM | Cullinan Oncology, Inc. | 11 Feb 2022 | 2 | $0 | 4 | Acting Chief Scientific Officer, Biologics | 15 Feb 2022, 15:48 |
| CGEM | Cullinan Oncology, Inc. | 08 Sep 2021 | 3 | -$265,650 | 4 | Acting Chief Scientific Officer, Biologics | 09 Sep 2021, 16:15 |
| CGEM | Cullinan Oncology, Inc. | 10 Aug 2021 | 3 | -$249,700 | 4 | Acting Chief Scientific Officer, Biologics | 26 Aug 2021, 19:11 |